Corpus Intelligence EBITDA Bridge — UNION HOSPITAL CLINTON 2026-04-27 03:04 UTC
EBITDA Bridge — UNION HOSPITAL CLINTON
CCN 151326 | IN | 25 beds | Current EBITDA $5.3M → Pro Forma $6.9M (+$1.6M)
🛡️ Public data only — no PHI permitted on this instance.
EBITDA BRIDGE  ·  CCN 151326

UNION HOSPITAL CLINTON
value-creation walk.

7-lever RCM bridge from current EBITDA to pro-forma — denial / underpay / DAR / coding / contract / cost discipline / cash acceleration. Each lever shows current vs benchmark target with data provenance.

$30.1M
Net Revenue HCRIS
$5.3M
Current EBITDA COMPUTED
+$1.6M
RCM EBITDA Uplift
$6.9M
Pro Forma EBITDA
+526bps
Margin Improvement
$1.2M
WC Released (1x)

Bridge Realization Estimate

ML model predicts what fraction of the bridge is achievable (accuracy: 60%, n=5,839)

62%
Realization (C)
$1.6M
Modeled Uplift
$982K
Risk-Adjusted
-$603K
Execution Discount
Occupancy RateLower Occupancy Rate reduces execution likelihood
Bed CountHigher Bed Count increases execution likelihood
Revenue per BedRevenue per Bed has minimal effect on execution
Commercial Payer %Commercial Payer % has minimal effect on execution
Net-to-Gross RatioNet-to-Gross Ratio has minimal effect on execution

Expected realization: 62% of modeled bridge. Strengths: Bed Count. Risks: Occupancy Rate. Risk-adjusted uplift: $1.0M (vs $1.6M modeled).

EBITDA Bridge — 7 RCM Levers

Each bar shows the annual EBITDA impact at full run-rate. Revenue levers increase top-line; cost levers reduce operating expense; cash acceleration releases working capital. Calibrated to published research bands (Denial 12%→5% = $8-15M on $400M NPR).

Cost to Collect
Cost Savings | 12mo ramp
$602K
+200bp
Denial Rate Reduction
Revenue | 12mo ramp
$596K
+198bp
A/R Days Reduction
Cash Accel | 9mo ramp
$367K
+122bp
Clean Claim Rate
Cost Savings | 6mo ramp
$19K
+6bp
Total EBITDA Impact$1.6M

Lever Detail

Each value shows its data source. SELLER = seller data room, DEFAULT = model default, BENCHMARK = P75 peer benchmark.

LeverCurrentTargetRevenueCostEBITDAWCRamp
Cost to Collect4.5% DEFAULT2.5% BENCHMARK$0$602K$602K$012mo
Denial Rate Reduction12.0% DEFAULT6.5% BENCHMARK$580K$17K$596K$012mo
A/R Days Reduction52.00 DEFAULT38.00 BENCHMARK$92K$274K$367K$1.2M9mo
Clean Claim Rate88.0% DEFAULT96.0% BENCHMARK$0$19K$19K$06mo
Net Collection Rate93.5% DEFAULT47.9% BENCHMARK$0$0$0$018mo
CDI / Case Mix Index135.0% DEFAULT142.0% BENCHMARK$0$0$0$018mo

Implementation Timing Curve

Linear ramp to full run-rate per lever. Month 0 = close date. Partners should expect 60-70% of total uplift realized by month 12.

LeverM0M3M6M9M12M18M24M36
Cost to Collect$0$151K$301K$452K$602K$602K$602K$602K
Denial Rate Reduction$0$149K$298K$447K$596K$596K$596K$596K
A/R Days Reduction$0$122K$244K$367K$367K$367K$367K$367K
Clean Claim Rate$0$10K$19K$19K$19K$19K$19K$19K
Cumulative$0$432K$863K$1.3M$1.6M$1.6M$1.6M$1.6M

Returns Sensitivity (IRR / MOIC)

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Green = exceeds 20% IRR hurdle. Amber = 15-20%. Red = below hurdle or loss. RCM uplift of $1.6M is added at exit.

Entry \ Exit9.0x10.0x11.0x11.5x12.0x
8.0x49% / 7.4x54% / 8.6x58% / 9.8x60% / 10.4x61% / 10.9x
9.0x44% / 6.2x49% / 7.3x53% / 8.3x55% / 8.8x56% / 9.4x
10.0x39% / 5.3x44% / 6.2x48% / 7.2x50% / 7.6x52% / 8.1x
11.0x35% / 4.5x40% / 5.4x44% / 6.2x46% / 6.7x48% / 7.1x
12.0x31% / 3.9x36% / 4.6x40% / 5.4x42% / 5.8x44% / 6.2x

Covenant Headroom (at 10x Entry, 6.5x Max Leverage)

8.5x
Entry Leverage
6.5x
Pro Forma Leverage
-0.0x
Headroom (turns)
-0%
EBITDA Cushion

Pro forma EBITDA can decline -0% before the 6.5x covenant trips. RCM uplift reduces leverage from 8.5x to 6.5x, adding 1.9 turns of cushion.

5-Year Value Creation Waterfall

EBITDA trajectory: 3% organic growth + RCM uplift ramp (full run-rate at month 18).

Base EBITDARCM UpliftTotalMargin
Entry$5.3M$5.3M17.7%
Year 1$5.5M+$1.1M$6.5M21.7%
Year 2$5.7M+$1.6M$7.2M24.0%
Year 3$5.8M+$1.6M$7.4M24.6%
Year 4$6.0M+$1.6M$7.6M25.2%
Year 5$6.2M+$1.6M$7.8M25.8%
$53.3M
Entry EV (10x)
$85.4M
Exit EV (11x)
$32.1M
Value Created
$7.8M
Exit EBITDA
$8.5M
Organic Growth
$15.8M
RCM Value Creation
$7.8M
Multiple Expansion

Achievement Sensitivity

What if we only achieve a fraction of each lever? 50% = conservative, 75% = base management case, 100% = plan, 120% = stretch.

Lever50%75%100%120%
Cost to Collect$301K$452K$602K$723K
Denial Rate Reductio$298K$447K$596K$716K
A/R Days Reduction$183K$275K$367K$440K
Clean Claim Rate$10K$14K$19K$23K
Total$792K$1.2M$1.6M$1.9M

Peer Context — Where This Hospital Sits

Key metrics vs 87 size-matched peers. Low percentile on margin/efficiency metrics = more room for improvement = larger bridge opportunity.

MetricHospitalP25P50P75Percentile
Op Margin17.7%-14.7%-5.2%6.8%
P87
Net-to-Gross31.2%29.6%33.4%47.9%
P37
Occupancy21.4%25.9%36.4%58.2%
P21
Rev/Bed$1.2M$620K$1.4M$2.0M
P40
Exp/Bed$992K$726K$1.6M$2.6M
P33

Bridge Methodology

Coefficients calibrated to published research bands: denial 12%→5% = $8-15M on $400M NPR. Current metrics estimated from HCRIS public data and ML predictions. Target metrics set at P75 peer benchmarks with 60% gap closure assumption. Revenue levers use NPR × delta × avoidable share. Cost levers use claims volume × cost per reworked claim. Working capital from AR reduction is one-time cash (not included in recurring EBITDA). Returns assume 5.5x leverage, 3% organic growth, 10%/yr debt paydown.

Data: HCRIS FY2022 | 6,123 hospitalsSources: HCRISML